Developed with the help of worldwide orthopaedic expert surgeons to improve efficiency and precision in total shoulder replacement, while supporting the advancement of personalized surgery, NextAR Shoulder has been successfully used to treat more than 200 patients in Europe and the United Statesfrom its first introduction in June 2021.
"I recall the first time the concept of NextAR technology was introduced to me. I was really surprised and enthusiastic and I immediately thought - I want to be part of this project!", said Prof. Dr. med. Matthias Zumstein at the Engeriedspital in Bern Switzerland. "Multiple wetlabs have assisted us in fine-tuning the surgical approach and have increased my confidence in working in close relationship with the technology. Now, after several surgeries performed, I can say that NextAR Shoulder represents a real added value to my surgical practice. Even though I believed in this project when we started working on it, I never thought we would achieve such an extremely beneficial result for the surgeon."
Prior to surgery, the surgeon uses a 3D virtual model of the patient's shoulder in order to choose the best implant and position for restoring the patient's unique anatomy. NextAR Shoulder enhances the preoperative strategy planning with unique intraoperative orientation assessments, allowing surgeons to accurately track the position of instruments and implants in real-time through the proprietary single-use NextAR TS Tracking System.
"Technology in shoulder replacement surgery is always advancing, but never so rapidly as I have seen in recent years. I can now plan the surgery more precisely than ever before using three-dimensional CT scanning and software to make the best decisions regarding optimal implant configuration for each individual patient and their unique anatomy." said John-Erik Bell, M.D. at the Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, New Hampshire. "The advantage of NextAR technology is in allowing me to precisely and accurately replicate my preoperative plan in real time, during surgery, without having to look away from my patient for navigation assistance. Once I have planned my optimal shoulder replacement strategy for my patient, I feel confident that NextAR will enable me to execute my plan even more accurately. Now that I have become comfortable using this technology, I can say that NextAR navigation is a real advantage for me during surgery, especially during complex cases."
NextAR Shoulder leverages synergy with the complete and convertible Medacta Shoulder System to provide surgeons with the possibility of tailoring the implant choice to the patient's needs. Moreover, this innovative technology is part of Medacta's MySolutions Personalized Ecosystem, an advanced network of digital solutions designed to improve patient outcomes and healthcare efficiency.
Medacta showcases its latest surgical innovations at numerous orthopaedics congresses:
• 12thVal d'Isère Advanced Shoulder Course, April 14-16, Val d'Isère, France
• Antwerp Shoulder Arthroplasty Course, April 21-22, Antwerp, Belgium
• Shoulder360° - The Comprehensive Shoulder Course, April 28-30, Miami, US
• Paris International Shoulder Course, July 7-9, Paris, France
• SECEC-ESSE, September 7-9, Dublin, Ireland
NextAR Shoulder is also supported by Medacta's M.O.R.E. Institute, which offers surgeons ongoing tailored help through a strong education network as they seek to incorporate new technologies.
Visit our brand-new portal nextar-shoulder.medacta.com to discover more about this unique technology.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medacta Group SA published this content on 13 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 April 2022 10:44:08 UTC.
Medacta Group SA is a Swiss-based company specialized in medical devices. The Company is specialized in the design, production and distribution of orthopedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.